A clinicalm trial to study the effects of a herbal drug Dawa-e-Musakkin in patients with anxity and Tensio
Phase 2
Completed
- Registration Number
- CTRI/2009/091/000761
- Lead Sponsor
- Hamdard National Foundation, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
?Age and Sex- 18-60 years, either sex
?Patients diagnosed as cases of generalized anxiety disorder according to DSM-IV diagnostic Criteria
Exclusion Criteria
?Pregnancy or lactation
?Women patients above 45 years of age( Post menopausal women)
?Patients with past or current history of cigarette smoking, drug or alcohol abuse.
?Patients of hyperthyroidism or hypothyroidism.
?Patients with a history of hypoglycemic episodes.
?Any cardiovascular /or chest diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in mean Hamilton Anxiety Rating scoreTimepoint: 4,8,12 week
- Secondary Outcome Measures
Name Time Method Improvement in performanceTimepoint: 3 months